So-Young International (NASDAQ:SY) Releases Earnings Results

So-Young International (NASDAQ:SY) issued its earnings results on Monday. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.06, FiscalAI reports. The business had revenue of $74.36 million for the quarter, compared to analyst estimates of $70.40 million. So-Young International had a negative net margin of 15.59% and a negative return on equity of 13.95%.

Here are the key takeaways from So-Young International’s conference call:

• Q2 revenue reached a record RMB 510 million, up 33% year over year, while aesthetic treatment revenue grew approximately 130% to RMB 331.4 million, marking the business’s 10th consecutive quarter of triple-digit growth.
• The clinic network expanded to 65 centers across 18 cities, with 47 centers profitable and 51 generating positive operating cash flow. Aesthetic-center gross margin improved 3.8 percentage points year over year to 28.1%, supported by higher utilization, procurement scale, and operating efficiencies.
• The group’s net loss narrowed 37% year over year to RMB 22.7 million, and management expects further margin improvement in Q3 and Q4 as fixed costs are diluted, the autumn-winter peak season approaches, and resources are shifted toward profitable businesses.
• Management highlighted strong customer engagement, including more than 250,000 active users, over 78,000 core members, and referrals accounting for more than 50% of new customers. The company also plans to launch its first fully intelligent AI-enabled clinic in Q4 to standardize care and improve operational efficiency.
• Other revenue streams weakened, with information and reservation services down 35% year over year, other services down 48.2%, and medical products and maintenance revenue down 2.8%. Q3 aesthetic-treatment revenue guidance of RMB 352 million to RMB 362 million implies growth of 91.7%–97.2%, a notable deceleration from Q2’s pace.

So-Young International Price Performance

NASDAQ:SY opened at $2.91 on Tuesday. So-Young International has a 1 year low of $1.28 and a 1 year high of $4.75. The business has a fifty day simple moving average of $1.93 and a two-hundred day simple moving average of $2.43. The company has a market capitalization of $295.66 million, a P/E ratio of -8.08 and a beta of 2.00.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised So-Young International from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. HRT Financial LP bought a new stake in shares of So-Young International during the 4th quarter valued at $32,000. Virtu Financial LLC purchased a new stake in shares of So-Young International in the fourth quarter worth about $33,000. Dimensional Fund Advisors LP purchased a new stake in shares of So-Young International in the third quarter worth about $63,000. Marshall Wace LLP bought a new position in shares of So-Young International in the fourth quarter valued at approximately $45,000. Finally, Jane Street Group LLC boosted its stake in So-Young International by 264.2% during the first quarter. Jane Street Group LLC now owns 36,419 shares of the company’s stock valued at $30,000 after buying an additional 26,419 shares during the period. 35.31% of the stock is owned by institutional investors.

About So-Young International

So-Young International Inc operates a leading digital marketplace and community platform focused on the medical aesthetic industry in China. Headquartered in Shanghai and founded in 2013, the company connects consumers seeking cosmetic treatments with a network of accredited clinics, licensed physicians and beauty service providers. Its online ecosystem offers a wealth of educational content, peer reviews and before-and-after galleries designed to help users make informed decisions about aesthetic procedures.

The company’s platform is accessible via web and mobile applications, where users can browse service packages, compare providers, read expert articles and schedule appointments directly through an integrated booking system.